Comprehensive. Microbiome. Service.

  • Customized study design.
  • Processing difficult sample types.
  • Massive reference database.
  • Flexible sequencing; Platform agnostic.
  • High level bioinformatics.
  • Custom analysis; Purpose-ready reporting.

Diversigen. Your single source.

Health and Disease

Your Metagenomics Collaborator

Diversigen has unparalleled experience in clinical microbiome study design and execution. We can partner in studies to help you improve current and develop future diagnostics and therapeutics.


Ensuring Stability of Food Production Pipelines

We can identify potential microbial impact on crops and livestock, helping you accelerate development of improved agricultural practices.

Oil And Gas

New Opportunities for Oil and Gas Production,
Enhancement and Risk Mitigation

We use metagenomics to detect microbes enabling you to enhance oil recovery, produce biofuels more effeciently, and reduce pipeline corrosion.

Welcome to Diversigen

Accelerate and transform discovery research and capitalize on the diverse opportunities of the microbiome with Diversigen.  

With years of experience, flexible sequencing, and bioinformatic capacity, we address unique customer needs, like designing custom sampling techniques, handling low biomass or dirty samples, employing sensitive levels of QA/QC or crafting unique study design.

Diversigen has extensive experience with highly diverse microbiome sample types and provides full project life cycle consulting services, building on research conducted at Baylor College of Medicine  in the Alkek Center for Metagenomics and Microbiome Research .

Subscribe To Our Mailing List

Join Us At Upcoming Events

Human Genome Meeting

Feb 28-Mar 2, 2016 
Houston, Texas For event details click here

The Molecular Medicine Tri Conference 2016

Diversigen Booth #332 March 6 - 11, 2016 San Francisco, CA For event details click here. View More

Featured News & Research

4D Pharmacueticals Produce Orally Delivered Live Biotherapeutics

Phase I Clinical Trial Generates Data on Mechanism of Action, Safety and Tolerability

4D pharma plc, a pharmaceutical company focusing on the development of live biotherapeutics, today provides the following update on the phase 1 clinical trial in respect of Blautix, its proprietary single strain live biotherapeutic for the treatment of Irritable Bowel Syndrome (IBS). Read More

How to Use Microbiome Signatures as Biomarkers

This paper provides an introduction to microbiome-based biomarkers and the application of biomarkers enabling targeted therapies, the role biomarkers play in reimbursement decisions for new therapies, an example process for biomarker identification/validation and more. Get Paper